🔎 Trials Near Me

Utama › Kanser Metastatik › Connecticut › New Haven

Kajian klinikal Kanser Metastatik di New Haven, CT

23 kajian untuk Kanser Metastatik sedang mencari peserta di lokasi dalam dan sekitar New Haven (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

Mengambil pesertaFasa 1/2
  • Avenzo Therapeutics Recruiting Site, New Haven
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT07193511

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Mengambil pesertaFasa 1/2
  • Yale Cancer Center, New Haven
Umur 12 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04585750

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Mengambil pesertaFasa 1
  • Yale - New Haven Hospital, New Haven
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06234605

A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours

Mengambil pesertaFasa 1/2
  • Yale Cancer Center-Yale University, New Haven
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07213817

A Study of ASP3082 in Adults With Advanced Solid Tumors

Mengambil pesertaFasa 1
  • Smilow Cancer Center at Yale New Haven Hospital, New Haven
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT05382559

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Mengambil pesertaFasa 3
  • Yale-New Haven Hospital, New Haven
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07218380

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Mengambil pesertaFasa 3
  • Yale University School of Medicine, New Haven
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06119581

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

Mengambil pesertaFasa 2
  • Yale University, New Haven
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT06311214

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Mengambil pesertaFasa 1/2
  • Avenzo Therapeutics Recruiting Site, New Haven
Umur 18 hingga 75 · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07038343

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Mengambil pesertaFasa 3
  • Smilow Cancer Hospital at Yale New Haven, New Haven
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT06072612

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Mengambil pesertaFasa 1
  • Yale Cancer Center, New Haven
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT07029399

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 1/2
  • Yale University School of Medicine, New Haven
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT05919264

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

Mengambil pesertaFasa 1/2
  • Crinetics Study Site, New Haven
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT07129252

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

Mengambil pesertaFasa 1/2
  • Yale University, New Haven
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT05691491

A Study of ASP1002 in Adults for Treatment of Solid Tumors

Mengambil pesertaFasa 1
  • Yale University Cancer Center, New Haven
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Jul 2026 · NCT05719558

A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 1
  • Exelixis Clinical Site #4, New Haven
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Jun 2026 · NCT06952010

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Mengambil pesertaFasa 1
  • Smilow Cancer Hospital (Yale University), New Haven
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Jun 2026 · NCT06040541

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

Mengambil pesertaFasa 1
  • Yale University, New Haven
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Jun 2026 · NCT06917079

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

Mengambil pesertaFasa 1/2
  • Yale School of Medicine, North Haven · 7 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Apr 2026 · NCT06413680

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

Mengambil pesertaFasa 3
  • Yale School of Medicine - Smilow Cancer Hospital, New Haven
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Apr 2026 · NCT06064877

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

Mengambil pesertaFasa 3
  • Yale Cancer Center, New Haven
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Feb 2026 · NCT06127407

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

Mengambil pesertaFasa 1
  • Yale Cancer Center, New Haven
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2025 · NCT05808634

Kajian Kanser Metastatik di bandar lain

Kajian lain di New Haven

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.